This morning, the Kelyniam Global (OTCMKTS:KLYG) stock is expected to come into focus among investors considering the fact that it had made a strong upward move last week.
On Friday, KLYG stock fell 0.36% to $0.14 with 20K shares, compared to its average volume of 102k shares. The stock has moved within a range of $0.1400 – 0.1500 after opening trade at $0.1406.
Receives U.S. Patent for Integrated Fixation Tabs
The company, which is involved in manufacturing and designing customised cranial implants, saw its stock jump by as much as 5% over the course of the previous week. The rally in the stock may have come about due to a key announcement from Kelyniam back on December 1. At the time, the company announced that it had received an Issue Notification from the United States Patent and Trademark Office in relation to a patent for its Integrated Fixation Tabs product.
It goes without saying that it was a significant development for the company and the product in question, which is why the rally in the Kelyniam Global stock was perhaps not surprising. The company had filed for the patent back in 2014 and as things stand, it is going to be in place up until 2037. It was a major development for the company also because of the fact that the product is another market leading product from Kelyniam Global and the patent is going to give the compay much needed protection.
“The integrated fixation patent is one of many marketplace-leading firsts for Kelyniam,” said Ross Bjella, Chairman and CEO. “The company was the first to use additive manufacturing to create custom PEEK implants, the first to receive FDA certification for temporal cutbacks and the first company to consistently deliver custom implants overnight. Receiving this patent validates Kelyniam’s commitment to innovation and our ability to bring leading technology to the market.”
KLYG stock is trading above the 10-Day and 20-Day Moving averages of $0.1238 and $0.1330. Moreover, the stock is trading is the neutral zone with RSI stands at 49.